Related content

Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma

By  

Neuroendocrinology, Vol. 84, Iss. 3, 2007-02 ,pp. : 196-211

Karger

Access to resources Recommend Favorite

Somatostatin Receptor Subtypes 2 and 5 Are Associated with Better Survival in Well-Differentiated Endocrine Carcinomas

By  

Neuroendocrinology, Vol. 89, Iss. 2, 2008-10 ,pp. : 223-230

Karger

Access to resources Recommend Favorite

Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)

By  

Neuroendocrinology, Vol. 84, Iss. 3, 2007-02 ,pp. : 212-215

Karger

Access to resources Recommend Favorite

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-12 ,pp. : 8-19

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 120-134

Karger

Access to resources Recommend Favorite